Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and ...

Researchers from Johns Hopkins University have identified three subtypes of senescent skin cells with distinct shapes, ...

Biomarkers, recommended vaccines, and managing MS in older patients and children are among topics covered in new CMSC MS care ...

The field of precision medicine has revolutionized our understanding and treatment of diseases, particularly in the realm of cardiopulmonary disorders. This ...

Among patients with oncogene-driven advanced NSCLC who were treated with TKIs, ctDNA clearance was associated with improved survival end points.

Onc.AI, a digital health company developing advanced AI-driven clinical management solutions for oncology, today announced that findings from a recent collaboration with global biopharma company GSK ...